 |
|
Stroke therapy window might be extended past nine hours for some
February 09, 2009Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms. The findings are published in the online edition of Radiology.
"Stroke is the third leading cause of death in the U.S.," said the study's lead author, William A. Copen, M.D., Director of Advanced Magnetic Resonance Neuroimaging at Massachusetts General Hospital (MGH) in Boston. "Every hour that we can add to the treatment window would allow vastly more stroke patients to be treated with potentially life-saving therapy."
The most common type of stroke is called ischemic stroke. These strokes occur when a blood clot blocks a blood vessel supplying blood to the brain. Some ischemic strokes can be treated with thrombolytic, or clot-busting, therapy using tissue plasminogen activator (t-PA), which helps dissolve the blockage. However, the window of opportunity to safely administer the medication is generally considered to be just three hours. Because few patients get to the hospital to be diagnosed and treated within that time frame, fewer than seven percent of patients receive the drug.
In this retrospective study, researchers analyzed the test results of 109 ischemic stroke patients at MGH. The testing methods included two different MRI scanning techniques: perfusion MRI, which measures blood flow in the brain, and diffusion MRI, which measures the movement of water molecules in tissue.
"Comparing the lesions that we see in these two MR images reveals which areas of the brain are threatened by a lack of blood flow, but could still be salvageable," Dr. Copen said. "A mismatch between the lesions suggests that a patient might still benefit from thrombolytic therapy."
In the study, most patients with blockage in a proximal artery, close to the base of the brain, continued to demonstrate a diffusion-perfusion mismatch between nine and 24 hours after the onset of their strokes.
"Patients who have a mismatch have been successfully treated up to nine hours after stroke onset, which is already much longer than the guidelines allow, Dr. Copen said. "Our findings suggest a need for a clinical trial to measure the effectiveness of thrombolytic therapy more than nine hours after the onset of an ischemic stroke."
Radiological Society of North America
In this retrospective study, researchers analyzed the test results of 109 ischemic stroke patients at MGH. The testing methods included two different MRI scanning techniques: perfusion MRI, which measures blood flow in the brain, and diffusion MRI, which measures the movement of water molecules in tissue.
"Comparing the lesions that we see in these two MR images reveals which areas of the brain are threatened by a lack of blood flow, but could still be salvageable," Dr. Copen said. "A mismatch between the lesions suggests that a patient might still benefit from thrombolytic therapy."
In the study, most patients with blockage in a proximal artery, close to the base of the brain, continued to demonstrate a diffusion-perfusion mismatch between nine and 24 hours after the onset of their strokes.
"Patients who have a mismatch have been successfully treated up to nine hours after stroke onset, which is already much longer than the guidelines allow, Dr. Copen said. "Our findings suggest a need for a clinical trial to measure the effectiveness of thrombolytic therapy more than nine hours after the onset of an ischemic stroke."
Radiological Society of North America
Ischemic Stroke Current Events and Ischemic Stroke News RSSResearch: Migraine and cardiovascular disease: Systematic review and meta-analysis
Migraine with aura (temporary visual or sensory disturbances before or during a migraine headache) is associated with a twofold increased risk of stroke, finds a study published on bmj.com today.
Smoking gun: just 1 cigarette has harmful effect on the arteries of young healthy adults
Even one cigarette has serious adverse effects on young adults, according to research presented by Dr. Stella Daskalopoulou at the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
Study: Added oxygen during stroke reduces brain tissue damage
Scientists have countered findings of previous clinical trials by showing that giving supplemental oxygen to animals during a stroke can reduce damage to brain tissue surrounding the clot.
Shingles raises risk of stroke by 30 percent or more in adults
Adults with shingles were about 30 percent more likely to have a stroke during a one-year follow-up than adults without shingles, in a study reported in Stroke: Journal of the American Heart Association.
Estrogen can reduce stroke damage by inactivating protein
Estrogen can halt stroke damage by inactivating a tumor-suppressing protein known to prevent many cancers, Medical College of Georgia researchers say.
Mayo Clinic Researchers Find Previous Exercise Helps Stroke Patients Recover Faster
A person who has exercised regularly prior to the onset of a stroke appears to recover more quickly, say researchers from Mayo Clinic in Florida, who led a national study.
Ben-Gurion U discovers drug can prevent epilepsy following traumatic brain injury
Dr. Alon Friedman, a neurosurgeon, professor and researcher at Ben-Gurion University of the Negev, working with researchers from UC Berkeley, California have identified a TGF Beta Blocker that when given to rats prevents epilepsy after brain damage.
Annual costs of stroke in U.S. children at least $42 million
Stroke in children costs at least $42 million annually in the United States, researchers report in Stroke: Journal of the American Heart Association.
Blood stem cell growth factor reverses memory decline in mice
A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found.
CPAP treatment linked to lower mortality in stroke patients with OSA
Stroke patients with obstructive sleep apnea (OSA) who undergo treatment with continuous positive airway pressure (CPAP) following their stroke may substantially reduce their risk of death.
More Ischemic Stroke Current Events and Ischemic Stroke News Articles
 |
Acute Ischemic Stroke: Imaging and Intervention by R.G. Gonzalez (Author), J.A. Hirsch (Author), W.J. Koroshetz (Author), M.H. Lev (Author), P. Schaefer (Author) This timely book provides basic, practical and up-to-date information on how to use imaging to diagnose and treat patients with acute ischemic stroke. Written by physicians from the Massachusetts General Hospital and faculty from the Harvard Medical School, the book distills years of experience in the day-to-day management of acute stroke patients, as well as leading-edge basic and clinical research, into a practical guide. With the growing awareness that modern CT and MR imaging can meaningfully improve the outcome of the acute stroke patient, this book provides the practical information to advance the capacities of providers in delivering the most advanced care for this disease. |
 |
Women, Stroke and the Red Dress: Cerebrovascular Disease in Women In most age groups, more men than women will have a stroke in a given year. However, more than half of total stroke deaths occur in women. At all ages, more women than men die of stroke. This talk will discuss the reasons for these disparities throughout a women's lifetime. |
 |
Management of Ischemic Stroke by Stanley N. Cohen M.D. (Author) This comprehensive text gives practical management guidelines to those managing the patient with stroke. The first part of the book reviews emergency management of the stroke patient, subacute management in the ICU, stroke rehabilitation, management in the first two months post-stroke including discussion of risk management, and chronic stroke problems including post-stroke pain, depression, aphasia, sexual relationships, and physical activities. The second part of the book addresses the specific causes of stroke and underlying pathophysiology. Common and uncommon causes are reviewed. Together, the coverage forms an unparalleled guide that tells you how to treat stroke patients effectively. |
 |
Preventing Ischemic Events: Advances in Antiplatelet Therapy (NCME Video 733) Also With: Network For Continuing Medical Education (Primary Contributor), Alan T. Hirsch (Primary Contributor), Eric C. Ras (Primary Contributor), Eric J. Topol (Primary Contributor) Atherosclerosis is a systemic disease that contributes to the death of 500,000 Americans by myocadial infarction and 150,000 Americans by stroke each year. In addition, peripheral arterial disease affects over 7 million Americans, two thirds of whom are undiagnosed. The modification of medical and lifestyle risk factors (e.g. diet, exercise, hypertension, smoking, and diabetes) and the daily administration of aspirin have been shown to save lives. However, aspirin is a relatively weak antiplatelet agent in that it interferes with one of the less significant intracellular processes that cause platelets to bind together. In this video, Drs. Hirsch, Raps, and Topol explore the role of new antiplatelet therapies in myocardial infarction, stroke, and peripheral arterial disease. Insights into... |
 |
Ischemic Stroke: An Atlas of Investigation and Treatment (Atlases of Investigation and Management) by Isaac E., M.D. Silverman (Author), Marilyn M., M.D. Rymer (Author), Louis R. Caplan (Foreword), Gary R. Spiegel (Foreword), Robert E. Schmidt (Foreword) In the past three decades, the diagnosis and treatment of stroke has changed at a phenomenal rate since the first use of CT scans and early studies using thrombolytic agents. In the last decade, the stroke specialist has seen the introduction of new therapies versus carotid endarterectomy; mechanical embolectomy and other catheter-delivered agents and devices; novel thrombolytic agents; drugs to limit hematoma expansion; antithrombotic agents for secondary stroke prevention and other neuroprotective strategies.Advanced techniques such as the treatment of aneurysms by neurosurgical clipping versus endovascular coiling, and neurosurgery for intracerebral hemorrhage and the malignant MCA stroke syndrome have been studied, offering a promising look into the future. It must not be forgotten... |
 |
Stroke Awareness Stroke is the third leading cause of death and the most common cause of adult disability. Because the current window of opportunity for treatment is only three hours you need to act quickly in recognizing a stroke. In this program a renowned team of multidisciplinary specialists discuss a full range of issues related to strokes from warning signs to diagnosis and treatment, prevention and surgical therapies. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Prevention and Treatment of Ischemic Stroke: Blue Books of Practical Neurology Series (Blue Books of Neurology) by Scott Eric Kasner MD (Author), Philip B. Gorelick MD MPH (Author) Provides truly practical evidence and advice to provide to the multitude of clinicians who care for patients with stroke. It is the most up to date and authoritative clinical text on both prevention (includes Epidemiology) and management (including critical care) of ischemic stroke patients (85% of strokes are ischemic). Evidence-based approach will cover treatment and prevention options for both primary and secondary ischemic stroke. |
 |
Acute Ischemic Stroke: An Evidence-based Approach by David M. Greer (Editor) This focused book deals clearly and concisely with the principles of management of patients with acute ischemic stroke (AIS). It emphasizes the published and verifiable evidence in support of these principles, and highlights the areas of limited evidence. Best evidence is provided for the current standard treatment of acute ischemic stroke, including intravenous chemical thrombolysis, intra-arterial approaches, blood pressure management, and anti-thrombotic therapy. More modern techniques are also described, such as the use of mechanical devices to evacuate a thrombus, induced hypertension, hyper-oxygenation (hyperoxia), and neuroprotective or neuroregeneration agents. Hallmark features include: Focused on acute ischemic stroke, the most rapidly growing area of stroke... |
 |
Transient Ischemic Attack and Stroke: Diagnosis, Investigation and Management (Cambridge Medicine) by Sarah T. Pendlebury (Author), Matthew F. Giles (Author), Peter M. Rothwell (Author) Accurate diagnosis, appropriate investigation, reliable risk stratification, and urgent treatment are essential after TIA and minor stroke and can reduce the risk of stroke recurrence by up to 80%. This book reviews recent developments in each of these areas. To reflect the fact that TIAs and minor strokes are simply one end of the clinical spectrum of cerebrovascular disease, the book also covers the management of major stroke, and long-term outcomes - such as cognitive impairment - which can complicate all types of cerebrovascular events. The book is therefore a comprehensive primer in stroke medicine. Written by a leading team of researchers in the field, this book will be of interest to neurologists, stroke physicians, and all others with an interest in stroke. |
 |
Ischemic Stroke (Advances in Neurology) by H.J.M. Barnett (Author), Julien Bogousslavsky (Author), Heather Meldrum (Author) John P. Robarts Research Institute, Ontario, Canada. Text provides an overview of the most current and effective advances in the diagnosis and management of ischemic stroke. Includes the risk factors, prevention, neurologic consequences, and rehabilitation. DNLM: Cerebrovascular Accident. |
| © 2009 BrightSurf.com |